Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 332

1.

Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.

Ammassari A, Murri R, Pezzotti P, Trotta MP, Ravasio L, De Longis P, Lo Caputo S, Narciso P, Pauluzzi S, Carosi G, Nappa S, Piano P, Izzo CM, Lichtner M, Rezza G, Monforte A, Ippolito G, d'Arminio Moroni M, Wu AW, Antinori A; AdICONA Study Group.

J Acquir Immune Defic Syndr. 2001 Dec 15;28(5):445-9.

PMID:
11744832
2.

Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy.

Heath KV, Singer J, O'Shaughnessy MV, Montaner JS, Hogg RS.

J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):211-7.

PMID:
12394800
3.

Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Côte d'Ivoire.

Eholié SP, Tanon A, Polneau S, Ouiminga M, Djadji A, Kangah-Koffi C, Diakité N, Anglaret X, Kakou A, Bissagnené E.

J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):355-8.

PMID:
17438479
4.

Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.

Eldred LJ, Wu AW, Chaisson RE, Moore RD.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jun 1;18(2):117-25.

PMID:
9637576
5.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
6.

Patient-reported nonadherence to HAART is related to protease inhibitor levels.

Murri R, Ammassari A, Gallicano K, De Luca A, Cingolani A, Jacobson D, Wu AW, Antinori A.

J Acquir Immune Defic Syndr. 2000 Jun 1;24(2):123-8.

PMID:
10935687
7.

Relationship between HAART adherence and adipose tissue alterations.

Ammassari A, Antinori A, Cozzi-Lepri A, Trotta MP, Nasti G, Ridolfo AL, Mazzotta F, Wu AW, d'Arminio Monforte A, Galli M; AdICoNA Study Group. LipoICoNA Study Group.

J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S140-4.

PMID:
12562038
8.

Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.

Gordillo V, del Amo J, Soriano V, González-Lahoz J.

AIDS. 1999 Sep 10;13(13):1763-9.

PMID:
10509579
9.
11.

Predictors of short-term success of antiretroviral therapy in HIV infection.

Oette M, Kroidl A, Göbels K, Stabbert A, Menge M, Sagir A, Kuschak D, O'hanley T, Bode JG, Häussinger D.

J Antimicrob Chemother. 2006 Jul;58(1):147-53. Epub 2006 May 10.

PMID:
16687458
12.

Antiretroviral therapy adherence in persons with HIV/AIDS in Cuba.

Aragonés C, Sánchez L, Campos JR, Pérez J.

MEDICC Rev. 2011 Apr;13(2):17-23.

13.

Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study.

Reynolds NR, Testa MA, Marc LG, Chesney MA, Neidig JL, Smith SR, Vella S, Robbins GK; Protocol Teams of ACTG 384, ACTG 731 and A5031s.

AIDS Behav. 2004 Jun;8(2):141-50.

PMID:
15187476
15.

Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial.

Gibb DM, Goodall RL, Giacomet V, McGee L, Compagnucci A, Lyall H; Paediatric European Network for Treatment of AIDS Steering Committee.

Pediatr Infect Dis J. 2003 Jan;22(1):56-62.

PMID:
12544410
16.

Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.

Protopopescu C, Raffi F, Roux P, Reynes J, Dellamonica P, Spire B, Leport C, Carrieri MP; ANRS CO8 APROCO-COPILOTE Study Group.

J Antimicrob Chemother. 2009 Sep;64(3):599-606. doi: 10.1093/jac/dkp232. Epub 2009 Jul 14.

PMID:
19602563
17.

Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.

Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti JP; APROCO cohort study group.

Soc Sci Med. 2002 May;54(10):1481-96.

PMID:
12061483
19.

Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients.

Cicconi P, Cozzi-Lepri A, Castagna A, Trecarichi EM, Antinori A, Gatti F, Cassola G, Sighinolfi L, Castelli P, d'Arminio Monforte A; ICoNA Foundation Study Group.

HIV Med. 2010 Feb;11(2):104-13. doi: 10.1111/j.1468-1293.2009.00750.x. Epub 2009 Sep 1.

20.

Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea.

de Jong BC, Prentiss D, McFarland W, Machekano R, Israelski DM.

J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):43-6.

PMID:
15608523

Supplemental Content

Support Center